Episodes

  • Ep 111 - Ethicon’s Tom O’Brien explains the design – and critical need for - its new surgical stapler

    Ep 111 - Ethicon’s Tom O’Brien explains the design – and critical need for - its new surgical stapler
    Jul 29 2022
    In this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture and a 27% greater articulation span, as well as software that provides real-time haptic and audible device feedback to help enable surgeons to make critical adjustments during procedures. Executive Editor Life Sciences Chris Newmarker conducts that interview and brings his Newmarker’s Newsmakers hitting upon news from Stryker, Pear Therapeutics, Dexcom and 3M. We also talk about the world’s largest orthopedics companies (find the list here https://www.massdevice.com/10-largest-orthopedic-device-companies-in-the-world-2022/) and the current spate of disappointing earnings reports from medical device companies If you’re interested in learning more about our upcoming DeviceTalks West event, join Editorial Director Tom Salemi on this short webinar. https://event.on24.com/wcc/r/3878353/5BD2F587B74A5106D4FFC61E92BC6354 Subscribe on all major podcast players.
    Show More Show Less
    48 mins
  • Ep 110 - Camille Chang Gilmore shares Boston Scientific’s successful approach to hitting many DEI goals

    Ep 110 - Camille Chang Gilmore shares Boston Scientific’s successful approach to hitting many DEI goals
    Jul 22 2022
    In this episode, Camille Chang Gilmore, vice president, human resources and global chief diversity officer, explains why she accepted Boston Scientific CEO Mike Mahoney’s offer to help lead the company’s diversity and inclusion efforts. This company’s work led to the creation of multiple programs promoting equity and combatting racism, earning Boston Scientific multiple awards and recognition from outside the company. She also shares as personal memory that speaks to the success she’s seen. This episode is brought to you by KNF. In this week’s Newmarker’s Newsmakers, Executive Editor Chris Newmarker brings a bounty of big news items from Synchron, Amazon, Intuitive, J&J and iRhythm.
    Show More Show Less
    59 mins
  • Ep 109 - Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results

    Ep 109 - Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
    Jul 1 2022
    In this episode, Boston Scientific CEO Michael Mahoney makes his DeviceTalks Weekly Podcast debut. In this jam-packed interview, Mahoney walks us through the cultural changes Boston Scientific has made since he joined the company a decade ago. He explains how restructuring has helped to identify leaders rather than managers. How Boston Scientific encourages people to take risks. Where does Boston Scientific see growth in markets and technologies. (We ask if Boston needs a surgical robotics platform.) Mahoney also explains how Boston Scientific knows when to let an opportunity go. We talk about experiences from his own career that others can take us lessons. Mahoney also explains what co-founder Pete Nicholas, who passed away recently, meant to the company, and what Boston Scientific will look like in five years. How will Boston Scientific move forward if the economy weakens. This episode is sponsored by PSN Labs. Executive editor Chris Newmarker brings his #NewmarkersNewsmakers – Cardinal Health, Acutus Medical, Medtronic and Boston Scientific. We also walk through a list of Medical Device companies are responding to the SCOTUS’s overturning Roe v. Wade and what this might mean for healthcare care data collection.
    Show More Show Less
    1 hr and 3 mins
  • Ep 108 - How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market

    Ep 108 - How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
    Jun 24 2022
    In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific. Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer. This episode is sponsored by AcuityMD. Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.
    Show More Show Less
    1 hr and 13 mins
  • Ep 107 - Can Moon Surgical fill critical role in the OR? Analyst Matson’s take on J&J, Medtronic and more

    Ep 107 - Can Moon Surgical fill critical role in the OR? Analyst Matson’s take on J&J, Medtronic and more
    Jun 17 2022
    In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he downgraded Medtronic and his take on supply chain issues. The rest of the episode will focus on Moon Surgical, which recently closed on a $31 million Series A to build a new robot that could lend critical assistance to surgeons. We speak with CEO Ann Osdoit about the company’s plans as well as investor and advisor Steve Oesterle, formerly of Medtronic. Oesterle also gives his assessment of the broader medical device-technology convergence including some fascinating forecasts for Verily. This episode is sponsored by KNF. Also hear more information about our upcoming DeviceTalks Tuesdays session and DeviceTalks West in-person meeting.
    Show More Show Less
    1 hr and 19 mins
  • Ep 106 - Fly into to the Data Zone! -A peak into Stryker’s playbook; What Oracle may do with Cerner

    Ep 106 - Fly into to the Data Zone! -A peak into Stryker’s playbook; What Oracle may do with Cerner
    Jun 10 2022
    This week listeners will get to hear how Stryker is incorporating Vocera, Gauss and other tech into its DRE strategy. We’ll get a visit from fellow podcaster Keith Figlioli of LRV Health to talk about Oracle’s acquisition of Cerner. And Chris “WorkLord” Newmarker brings a star-studded Newmarker’s Newsmakers feature Smith & Nephew, GE Healthcare, Ethicon, Medtronic, and Moon Surgical. Thank you to Flexan for sponsoring this episode! Go to Flexan.com. Newmarker’s Newsmakers 5. Smith & Nephew makes historic move? https://www.massdevice.com/smithnephew-moving-out-of-hull-uk/ 4.GE Healthcare keeps making news! https://www.massdevice.com/ge-healthcare-workload-management-software-radiologists/ 3. Have you seen Ethicon's stapler? https://www.massdevice.com/ethicon-launches-next-gen-surgical-stapler/ 2. Medtronic adds more Neuromed Knowhow https://www.massdevice.com/medtronic-announces-new-chief-medical-officer-for-neuromodulation-unit/ 1. Moon launches robotic surgery bid https://www.massdevice.com/moon-surgical-raises-31m-robotic-surgery-system/
    Show More Show Less
    1 hr and 20 mins
  • Ep 105 - Deep look into Medtech Mergers, Investor frustration; Bonus: Medtronic moves against health inequity

    Ep 105 - Deep look into Medtech Mergers, Investor frustration; Bonus: Medtronic moves against health inequity
    Jun 3 2022
    In this episode, we’ll take a deeper look into our Newmarker’s Newsmakers with Andrew Jay, general partner at the Borna Health Fund, a hedge fund that invests in medical technology companies. We’ll take about Stryker’s recent regulatory success; Quidel’s game-changing acquisition; Medtronic’s dialysis deal with DaVita and shareholder votes against executive pay at Masimo. We’ll also take a deeper look into the swirling speculation that Johnson & Johnson could look to buy Boston Scientific. In the second half of the show, we’ll run our latest MedtronicTalks podcast episode that highlighted the work the company and industry is doing to identify and combat healthcare inequity. Finally, we’ll also hear some helpful advice on cybersecurity. #5. https://www.massdevice.com/strykers-spine-guidance-software-fda-clearance/ #4 https://www.massdevice.com/quidel-ortho-clinical-diagnostics-combine/ #3 https://www.massdevice.com/medtronic-davita-kidney-device-company/ #2 https://www.massdevice.com/masimo-no-vote-executive-pay/ #1 https://www.drugdeliverybusiness.com/dexcom-quashes-insulet-merger/ https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/ Subscribe on any major podcast channel.
    Show More Show Less
    1 hr and 22 mins
  • Ep 104 - DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5

    Ep 104 - DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
    May 20 2022
    In this episode the MassDevice editorial team will break down all the action at DeviceTalks Boston. You’ll also hear from keynote speaker Eric Benjamin, executive vice president of innovation, strategy and digital products, at the company. To read MassDevice’s coverage of DeviceTalks Boston go here. https://www.massdevice.com/tag/devicetalks-boston/ Thank you to our sponsor DeepDyve. To try out DeepDyve go to https://get.deepdyve.com/devicetalks/
    Show More Show Less
    1 hr and 26 mins